On the contrary, Lamin A/C levels are described as risk biomarkers for colorectal cancer patients, given that patients with A-type lamin-expressing tumors have significantly worse prognosis than patients with A-type lamin negative tumors and Lamin A/C overexpression in a colorectal cancer cell line increases cell motility and invasion by down-regulating cell adhesion (Willis et al., 2008). This evidence concerns the gene LMNA and colorectal cancer.